Merck KGaA’s Stimuvax Is First Therapeutic Vaccine For Lung Cancer In Phase III
A therapeutic vaccine being developed for non-small cell lung cancer should be going into Phase III testing this autumn.
This entry was posted on Wednesday, June 21st, 2006 at 5:42 pm and is filed under Research, Treatment. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.